ÌÇÐÄÊÓÆµ

Venture

Now A Solo GP Firm, Refactor Capital Closes $30M For Fund II

According to with the Securities & Exchange Commission (SEC), Burlingame, CA-based successfully closed $30 million for its second fund.

Subscribe to the Crunchbase Daily

The filing states that the fund first closed capital in early May of this year, the day after the firm to raise Fund II. Refactor’s second fund is materially smaller than its first, a closed in May 2016, likely due to changes in its management and leadership team. Especially these days, it’s unusual for a venture firm to raise smaller second funds after deploying their first flagship funds. But, at the same time, it’s unusual for general partners to peel off from the firm. With a headcount of one on the GP side, the firm can afford to raise less capital.

Refactor’s sole general partner is , a product management professional who, before moving into venture capital, served stints at Microsoft and Google. He was also head of mobile at Netflix between 2011 and 2012 and as a senior product manager of LinkedIn’s premium subscription features the following year.

Bilimoria joined Andreessen Horowitz as a partner in late 2013, where he stayed until launching Refactor Capital in January 2016 with co-founding general partner . Prior to starting Refactor Capital with Billimoria, Lee spent nearly 8 years as the managing partner of , historically among the most prolific seed-stage venture funds in the Bay Area. A lawyer by training, Lee previously served as corporate counsel to Google and briefly led StumbleUpon’s business development efforts before transitioning into venture.

Lee stepped back from his general partner role sometime before the initial filing for Fund II went through on April 30th. Lee remains part of the firm, staying on as chairperson. Lee that “[b]ecoming Chairman will keep me involved with Refactor, and also allow me to spend more time in Los Angeles, work more closely with current Refactor portfolio founders and pursue new adventures.â€

While at Andreessen Horowitz, Billimoria helped that firm launch , and that tendency to find and fund ventures in biotech and life science continues to play out through Refactor’s investments. Refactor writes the bulk of its first checks at seed stage and primarily funds companies working in healthcare or biotech.

According to and on its own website, the firm has backed ventures aligned on one of several themes. On the theme of mental health and wellness, Refactor backed meditation service , self-styled sobriety school , nicotine gum-maker , and zero-alcohol beverage company .

Refactor has also made several investments in computational research and diagnostics companies, like , , , and . In the raw materials and manufacturing side, the firm has stakes in , , , and .

Outside the life sciences and biotech field, Refactor Capital has invested in select software and high-technology ventures including telecoms satellite-maker , supply chain and demand analytics provider , and the , which hopes to compete with the NYSE and Nasdaq by offering an IPO process and shareholder equity structure which it says is more favorable to technology companies.

Since the majority of companies in Refactor’s portfolio are still early on in the venture lifecycle, none of its portfolio companies have yet exited, according to Crunchbase data.

±õ±ô±ô³Ü²õ³Ù°ù²¹³Ù¾±´Ç²Ô:Ìý

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

67.1K Followers

CTA

Discover and act on private market opportunities with predictive company intelligence.

Copy link